Local Expression of Coagulation Factor X (FXa) is Increased in Response to Pressure Overload and Mediates Cardiac Hypertrophy and Fibrosis

被引：0
|
作者：
Guo, Xinji
Kolpakov, Mikhail
Hooshdaran, Bahman
Vlasenko, Liudmila
Schappell, William
Wang, Tao
Liu, Shaojun
Crandall, David
Andrade-Gordon, Patricia
Houser, Steven R.
Sabri, Abdelkarim
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Rivoraxaban; Antithrombotic therapy; Cardiac hypertrophy; Fibrosis; Inflammation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18832
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Stem Cell Antigen 1 Protects Against Cardiac Hypertrophy and Fibrosis After Pressure Overload
    Zhou, Heng
    Bian, Zhou-Yan
    Zong, Jing
    Deng, Wei
    Yan, Ling
    Shen, Di-Fei
    Guo, Haipeng
    Dai, Jia
    Yuan, Yuan
    Zhang, Rui
    Lin, Ya-Fen
    Hu, Xue
    Li, Hongliang
    Tang, Qi-Zhu
    HYPERTENSION, 2012, 60 (03) : 802 - +
  • [12] Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis
    Gao, Xiao-Ming
    Wong, Geoffrey
    Wang, Binghui
    Kiriazis, Helen
    Moore, Xiao-Lei
    Su, Yi-Dan
    Dart, Anthony
    Du, Xiao-Jun
    JOURNAL OF HYPERTENSION, 2006, 24 (08) : 1663 - 1670
  • [13] Analyzing gene expression profiles with preliminary validations in cardiac hypertrophy induced by pressure overload
    Gao, Jing
    Li, Yuhong
    Wang, Tongmei
    Shi, Zhuo
    Zhang, Yiqi
    Liu, Shuang
    Wen, Pushuai
    Ma, Chunyan
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (08) : 701 - 709
  • [14] Toll-Like Receptor 2 Mediates Cardiac Adaptive Response to Pressure Overload
    Higashikuni, Yasutomi
    Nagai, Ryozo
    Sata, Masataka
    CIRCULATION, 2012, 126 (21)
  • [15] TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
    Wang, Zhen
    Xu, Yao
    Wang, Menglong
    Ye, Jing
    Liu, Jianfang
    Jiang, Huimin
    Ye, Di
    Wan, Jun
    EBIOMEDICINE, 2018, 36 : 54 - 62
  • [16] Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction
    Zhang, Yan
    Zhang, Xiao-Fei
    Gao, Lu
    Liu, Yu
    Jiang, Ding-Sheng
    Chen, Ke
    Yang, Qinglin
    Fan, Guo-Chang
    Zhang, Xiao-Dong
    Huang, Congxin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (02): : 232 - 244
  • [17] Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis
    Tang, Chaoliang
    Yin, Guobing
    Huang, Chunxia
    Wang, Hongtao
    Gao, Jie
    Luo, Jianfeng
    Zhang, Zhetao
    Wang, Jiawu
    Hong, Junmou
    Chai, Xiaoqing
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [18] Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload
    Beetz, Nadine
    Rommel, Carolin
    Schnick, Tilman
    Neumann, Elena
    Lother, Achim
    Monroy-Ordonez, Elsa Beatriz
    Zeeb, Martin
    Preissl, Sebastian
    Gilsbach, Ralf
    Melchior-Becker, Ariane
    Rylski, Bartosz
    Stoll, Monika
    Schaefer, Liliana
    Beyersdorf, Friedhelm
    Stiller, Brigitte
    Hein, Lutz
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 101 : 145 - 155
  • [19] Sirt1 Mediates Pressure Overload-Induced Cardiac Hypertrophy and Failure in vivo
    Oka, Shinichi
    Alcendor, Ralph
    Zablocki, Daniela
    Zhai, Peiyong
    Yamamoto, Takanobu
    Sadoshima, Junichi
    CIRCULATION, 2011, 124 (21)
  • [20] Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure-Overload in Mice
    Suzuki, Kota
    Satoh, Kimio
    Shohei, Ikeda
    Kadomatsu, Kenji
    Shimokawa, Hiroaki
    CIRCULATION, 2014, 130
12345